Retraction Note: miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9

• Chao Yang,
• Yonghua Xu,
• Feng Cheng,
• Yuanchang Hu,
• Shikun Yang,
• Jianhua Rao,
• Xuehao Wang

Affiliations

Chao Yang

Department of Liver Surgery/Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory on Living Donor Liver Transplantation of National Health and Family Planning Commission of China

Yonghua Xu

Department of General Surgery, Yancheng City No.1 People’s Hospital/The Fourth Affiliated Hospital of Nantong University

Feng Cheng

Department of Liver Surgery/Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory on Living Donor Liver Transplantation of National Health and Family Planning Commission of China

Yuanchang Hu

Department of Liver Surgery/Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory on Living Donor Liver Transplantation of National Health and Family Planning Commission of China

Shikun Yang

Department of Liver Surgery/Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory on Living Donor Liver Transplantation of National Health and Family Planning Commission of China

Jianhua Rao

Department of Liver Surgery/Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory on Living Donor Liver Transplantation of National Health and Family Planning Commission of China

Xuehao Wang

Department of Liver Surgery/Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory on Living Donor Liver Transplantation of National Health and Family Planning Commission of China